This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walsh, R. A. Articles by Horwitz, L. D. Search for Related Content PubMed PubMed Citation Articles by Walsh, R. A. Articles by Horwitz, L. D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ATROPINE PROPRANOLOL HYDROCHLORIDE QUINIDINE QUINIDINE SULFATE

Circulation, Vol 60, 1053-1058, Copyright © 1979 by American Heart Association

ARTICLES

Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs

RA Walsh and LD Horwitz

Disopyramide resembles quinidine electrophysiologically, but its effect on left ventricular function has not been clarified. Twelve awake dogs were instrumented for measurement of cardiac output, left ventricular pressure and its maximal first derivative (dP/dt max), and left atrial and aortic pressures. Disopyramide or quinidine at identical, clinically relevant doses (1 and 5 mg/kg i.v.) was infused over 5 minutes at each level. Peak changes after disopyramide 1 mg/kg included increases in heart rate (34%), mean aortic pressure (24%) and systemic vascular resistance (33%), and decreases in stroke volume (16%) and dP/dt max (19%). With disopyramide at 5 mg/kg these changes were of greater magnitude (e.g., dP/dt -- 36%). Quinidine at both doses caused no changes except a 13% decrease in vascular resistance at 5 mg/kg. Heart rate with disopyramide increased after propranolol (1 mg/kg i.v.), was unchanged after atropine (0.1 mg/kg i.v.), and slowed after propranolol and atropine. Phenoxybenzamine (2 mg/kg i.v.) did not prevent the rise in systemic vascular resistance produced by disopyramide. Thus, disopyramide in clinical dosages exerts opposing direct and indirect effects on cardiac pacemakers and, unlike quinidine, is a potent myocardial depressant and vasoconstrictor in the conscious dog.

This article has been cited by other articles:

				E. Goldberg, R. Berdoff, G. Spivack, A. Haimowitz, and S. Tay Evaluation of the Vasodilator vs Inotropic Effect of Milrinone Using an Animal Model of Left Ventricular Failure: Reversal of Disopyramide Depression of the Myocardium with Milrinone Angiology, September 1, 1987; 38(9): 657 - 662. [Abstract] [PDF]

				J. S. Gottdiener, R. DiBianco, and R. D. Fletcher Effects of Antiarrhythmic Agents on Cardiac Function Angiology, April 1, 1982; 33(4): 228 - 238. [PDF]